Identification of residues in the neuronal α7 acetylcholine receptor that confer selectivity for conotoxin ImI

被引:60
作者
Quiram, PA [1 ]
Sine, SM [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, Receptor Biol Lab, Rochester, MN 55905 USA
关键词
D O I
10.1074/jbc.273.18.11001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To identify residues in the neuronal alpha(7) acetylcholine subunit that confer high affinity for the neuronal-specific toxin conotoxin ImI (CTx ImI), we constructed alpha(7)-alpha(1) chimeras containing segments of the muscle alpha(1) subunit inserted into equivalent positions of the neuronal alpha(7) subunit. To achieve high expression in 293 human embryonic kidney cells and formation of homo-oligomers, we joined the extracellular domains of each chimera to the M1 junction of the 5-hydroxytryptamine-3 (5HT-3) subunit, Measurements of CTx ImI binding to the chimeric receptors reveal three pairs of residues in equivalent positions of the primary sequence that confer high affinity of CTx ImI for alpha(7)/5HT-3 over alpha(1)/5HT-3 homooligomers. Two of these pairs, alpha(7)Trp(55)/alpha(1)Arg(55) and alpha Ser(59)/alpha(1)Gln(59), are within one of the four loops that contribute to the traditional non-alpha subunit face of the muscle receptor binding site. The third pair, alpha(7)Thr(77)/alpha(1)Lys(77), is not within previously described loops of either the alpha or non-alpha faces and may represent a new loop or an allosterically coupled loop. Exchanging these residues between alpha(1) and alpha(7) subunits exchanges the affinities of the binding sites for CTx ImI, suggesting that the alpha(7) and alpha(1) subunits, despite sequence identity of only 38%, share similar protein scaffolds.
引用
收藏
页码:11001 / 11006
页数:6
相关论文
共 30 条
[1]   HOMOMERIC AND NATIVE ALPHA-7 ACETYLCHOLINE-RECEPTORS EXHIBIT REMARKABLY SIMILAR BUT NONIDENTICAL PHARMACOLOGICAL PROPERTIES, SUGGESTING THAT THE NATIVE RECEPTOR IS A HETEROMERIC PROTEIN COMPLEX [J].
ANAND, R ;
PENG, X ;
LINDSTROM, J .
FEBS LETTERS, 1993, 327 (02) :241-246
[2]  
ANDRUE D, 1994, METHODS MOL BIOL PEP, V35, P139
[3]   Identification of residues in the adult nicotinic acetylcholine receptor that confer selectivity for curariform antagonists [J].
Bren, N ;
Sine, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :30793-30798
[4]  
CHIARA DC, 1992, BIOPHYS J, V61
[5]  
Cooper ST, 1997, J NEUROCHEM, V68, P2140
[6]   IDENTIFICATION OF A NEW COMPONENT OF THE AGONIST BINDING-SITE OF THE NICOTINIC ALPHA-7 HOMOOLIGOMERIC RECEPTOR [J].
CORRINGER, PJ ;
GALZI, JL ;
EISELE, JL ;
BERTRAND, S ;
CHANGEUX, JP ;
BERTRAND, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (20) :11749-11752
[7]   A NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR SUBUNIT (ALPHA-7) IS DEVELOPMENTALLY REGULATED AND FORMS A HOMOOLIGOMERIC CHANNEL BLOCKED BY ALPHA-BTX [J].
COUTURIER, S ;
BERTRAND, D ;
MATTER, JM ;
HERNANDEZ, MC ;
BERTRAND, S ;
MILLAR, N ;
VALERA, S ;
BARKAS, T ;
BALLIVET, M .
NEURON, 1990, 5 (06) :847-856
[8]   CHIMERIC NICOTINIC SEROTONERGIC RECEPTOR COMBINES DISTINCT LIGAND-BINDING AND CHANNEL SPECIFICITIES [J].
EISELE, JL ;
BERTRAND, S ;
GALZI, JL ;
DEVILLERSTHIERY, A ;
CHANGEUX, JP ;
BERTRAND, D .
NATURE, 1993, 366 (6454) :479-483
[9]   FUNCTIONAL-SIGNIFICANCE OF AROMATIC-AMINO-ACIDS FROM 3 PEPTIDE LOOPS OF THE ALPHA-7 NEURONAL NICOTINIC RECEPTOR-SITE INVESTIGATED BY SITE-DIRECTED MUTAGENESIS [J].
GALZI, JL ;
BERTRAND, D ;
DEVILLERSTHIERY, A ;
REVAH, F ;
BERTRAND, S ;
CHANGEUX, JP .
FEBS LETTERS, 1991, 294 (03) :198-202
[10]   STABLE EXPRESSION AND PHARMACOLOGICAL PROPERTIES OF THE HUMAN ALPHA(7) NICOTINIC ACETYLCHOLINE-RECEPTOR [J].
GOPALAKRISHNAN, M ;
BUISSON, B ;
TOUMA, E ;
GIORDANO, T ;
CAMPBELL, JE ;
HU, IC ;
DONNELYROBERTS, D ;
ARNERIC, SP ;
BERTRAND, D ;
SULLIVAN, JP .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 290 (03) :237-246